As a sector, the pharmaceutical industry’s carbon emissions are even greater than that of the automotive industry - in the region of 55% more emission intensive. Drug delivery devices and the primary and secondary packaging account for a proportion of the CO2 emissions of combination products based on their design. The urgency of action required for global GHG emissions reduction means that parenteral packaging suppliers cannot work in isolation if they are to reach these GHG reduction goals. The Alliance to Zero was established to directly address this issue, by adopting the principles of the circular economy to facilitate the transition of the pharma sector to net zero emissions by 2030. This webcast will introduce the ambition of the Alliance of Zero, explain the methodology and impact the association intends to have and how pharma suppliers can participate.
Drug Delivery Devices for Net Zero Emissions: A Pharma Supply Chain Collaboration
Join our webinar to learn about the ambition of the Alliance of Zero, understand the methodology and impact the association intends to have, and how pharma suppliers can participate. (Recording available)
10 a.m. (EST)
Key Learning Objectives:
Understand the objectives of the Alliance to Zero, as a membership association for pharma supply chain organizations.
Learn more about what a net zero emission concept for pharmaceutical manufacturing and supply chain would look like and the steps necessary to achieve it.
Understand how pharma suppliers can participate in the alliance and share the common goals to contribute directly to the reduction the scope 3 emissions for pharma clients.
Who Should Attend:
Innovation & Technology leaders
Quality/regulatory personnel in parenteral drug delivery
Formulation scientists and packaging engineers
Device development engineers and managers
Technical functions surrounding drug delivery systems
Extractable and leachable experts
Innovation & Business Development Manager
Sebastian Gerner is Innovation & Business Development Manager with Ypsomed Delivery Systems. He is driving the transition of Ypsomed from a linear take – make – waste economy towards a circular economy. He is a mechanical engineer with more than 10 years of medical device experience in various medical and pharmaceutical companies.
Dr. Dirk Vander Mierde
Dirk Vander Mierde joined Datwyler in 2011 and has held several positions in operations before taking up the position of site director in Datwyler Pharma Packaging Belgium in 2016. He is a chemical engineer, has a PhD in medical science and a global MBA.
Business Development Manager
Alexander Schäfer joined Sharp’s European Business Development team in 2014 as Business Development Manager. Before joining the Sharp team, Alexander worked during the last 20 years for a number of CMO’s/CDMO’s such as Catalent and NextPharma in different Sales & Marketing related roles covering clinical and commercial manufacturing and packaging services.
Head of Product Management Packaging Machines
Manuel Huber is Head of Product Management Packaging Machines with Körber’s Business Area Pharma. He joined Körber in 2013 and since acquired an extensive knowledge of secondary packaging solutions and machines for any kind of parenteral products and devices and build up a deep insight of the international pharma and biotech market. He graduated with a degree in Mechanical Engineering and holds an additional degree in Business Administration.